The latest closing stock price for CRISPR Therapeutics AG as of February 21, 2025 is 47.91.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,400 today, roughly 2 times their original investment - a 16.53% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 90.62, which is 89.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 36.52, which is 23.8% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 53.05.
An investor who bought $1,000 worth of CRISPR Therapeutics AG stock at the IPO in 2016 would have $2,400 today, roughly 2 times their original investment - a 16.53% compound annual growth rate over 8 years.
The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
The CRISPR Therapeutics AG 52-week high stock price is 90.62, which is 89.1% above the current share price.
The CRISPR Therapeutics AG 52-week low stock price is 36.52, which is 23.8% below the current share price.
The average CRISPR Therapeutics AG stock price for the last 52 weeks is 53.05.